Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
34,726,628
-
Shares change
-
-864,841
-
Total reported value, excl. options
-
$52,083,531
-
Value change
-
-$1,381,303
-
Put/Call ratio
-
8.9%
-
Number of buys
-
12
-
Number of sells
-
28
-
Price
-
$1.50
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2023
As of 30 Sep 2023 GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,726,628 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Artal Group S.A., NEA Management Company, LLC, Octagon Capital Advisors LP, VANGUARD GROUP INC, AXA S.A., ACADIAN ASSET MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 48 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.